Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy
QXDx BCR-ABL %IS kit achieves highest sensitivity for detecting disease remission in patients with chronic myeloid leukemia
QXDx BCR-ABL %IS kit achieves highest sensitivity for detecting disease remission in patients with chronic myeloid leukemia
Assay offers largest set of apolipoproteins commercially available
Scientists to present research demonstrating the use of Bio-Rad’s Droplet Digital technology for highly accurate copy number quantification, mutation detection, and single-cell sequencing.
Resin to be showcased as part of a comprehensive line of bioprocess workflow solutions
Bio-Rad Laboratories Inc. announced the launch of Clarity Max Western ECL Substrate, an enhanced chemiluminescent detection reagent
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
The multi-constituent control offers increased efficiency and confidence in test results
First Prospective Clinical Trial of Liquid Biopsy with Real-World Clinical Application